OMB
.report
Search
Biologics Compounding GFI
Human Drug Compounding, Repackaging, and Related Activities Regarding Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
21 USC 353b Outsourcing Facilities
Biologics Compounding GFI
OMB: 0910-0858
OMB.report
HHS/FDA
OMB 0910-0858
ICR 202405-0910-002
IC 248971
Biologics Compounding GFI
( )
Document [pdf]
Download:
pdf
|
pdf
File Type
application/pdf
File Title
Untitled document
Author
DHC
File Modified
2021-01-31
File Created
2021-01-31
© 2024 OMB.report |
Privacy Policy